4.510NOK+10.00%Mkt Cap: 137.67M $P/E: —Today
Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases. The company develops vaccines for the treatment cancer…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap137.67M $
Enterprise Value120.58M $
Revenue (TTM)51.97K $
Gross Profit51.97K $
Net Income (TTM)-1.14M $
Revenue/Share0.0002 USD
Last Price4.510 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees57
CountryNO
SectorHealthcare
IndustryBiotechnology
ISINNO0010714785
Valuation
P/E (Trailing)—
P/E (Forward)-32.49
PEG—
EV/EBITDA-48.03
EV/Revenue2319.95
P/S2642.91
P/B1.76
EPS (TTM)-0.47
EPS (Forward)-0.14
52W Range
1.44082% of range5.170
52W High5.170 NOK
52W Low1.440 NOK
Profitability
Gross Margin100.00%
Oper. Margin-2723.33%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-13.37%
ROA-12.25%
Growth
Revenue Growth75.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.75M $
CapEx (TTM)3.55K $
FCF Margin-3300.07%
FCF Yield-1.25%
Net Debt-4.58M $
Net Debt/EBITDA1.82
Balance Sheet
Debt/Equity0.03
Current Ratio12.66
Quick Ratio12.66
Book Value/Sh2.558 NOK
Cash/Share0.1570 NOK
Dividends
Fwd Div Rate1.000 NOK
Trail. Div Rate0.0000 NOK
Div. Yield29.76%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 27, 2025
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.000 NOK
Upside (mean)+10.9%
Target Range4.500 NOK – 5.500 NOK
NOK4.500+10.9% to meanNOK5.500
# Analysts2
Ownership
Shares Out.326.55M
Float213.69M
Insiders43.60%
Institutions19.04%
Technical
SMA 503.178 (+41.9%)
SMA 2002.971 (+51.8%)
Beta0.81
S&P 52W Chg18.16%
Avg Vol (30d)1.69M
Avg Vol (10d)1.76M
Technical Indicators
RSI (14)61.6
MACD0.2236
MACD Signal0.1191
MACD Hist.+0.1044
BB Upper4.237 NOK
BB Middle3.412 NOK
BB Lower2.586 NOK
BB Width48.42%
ATR (14)0.3292 NOK
Vol Ratio (20d)9.83x